BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23405208)

  • 21. Specific interaction of Egr1 and c/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene.
    Zhang F; Lin M; Abidi P; Thiel G; Liu J
    J Biol Chem; 2003 Nov; 278(45):44246-54. PubMed ID: 12947119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein beta and delta in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages.
    Liu YW; Tseng HP; Chen LC; Chen BK; Chang WC
    J Immunol; 2003 Jul; 171(2):821-8. PubMed ID: 12847250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCAAT/enhancer binding protein β negatively regulates progesterone receptor expression in human glioblastoma cells.
    Hansberg-Pastor V; González-Arenas A; Camacho-Arroyo I
    Mol Cell Endocrinol; 2017 Jan; 439():317-327. PubMed ID: 27663075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.
    Park BH; Kook S; Lee S; Jeong JH; Brufsky A; Lee BC
    J Biol Chem; 2013 Oct; 288(40):28656-67. PubMed ID: 23966000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4.
    Aguilar-Morante D; Morales-Garcia JA; Santos A; Perez-Castillo A
    Oncotarget; 2015 Feb; 6(6):4369-84. PubMed ID: 25738360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
    Klick DE; Shadley JD; Hines RN
    Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 10 17β-hydroxysteroid dehydrogenase expression is regulated by C/EBPβ in HepG2 cells.
    Rotinen M; Villar J; Celay J; Encío I
    J Steroid Biochem Mol Biol; 2010 Oct; 122(4):164-71. PubMed ID: 20638476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional repression of TFF1 in gastric epithelial cells by CCAAT/enhancer binding protein-beta.
    Sankpal NV; Mayo MW; Powell SM
    Biochim Biophys Acta; 2005 Apr; 1728(1-2):1-10. PubMed ID: 15777639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
    Bundy LM; Sealy L
    Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2.
    Koslowski M; Türeci O; Biesterfeld S; Seitz G; Huber C; Sahin U
    J Biol Chem; 2009 Oct; 284(42):28607-15. PubMed ID: 19652226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.
    Xiong L; Wu F; Wu Q; Xu L; Cheung OK; Kang W; Mok MT; Szeto LLM; Lun CY; Lung RW; Zhang J; Yu KH; Lee SD; Huang G; Wang CM; Liu J; Yu Z; Yu DY; Chou JL; Huang WH; Feng B; Cheung YS; Lai PB; Tan P; Wong N; Chan MW; Huang TH; Yip KY; Cheng AS; To KF
    Nat Commun; 2019 Jan; 10(1):335. PubMed ID: 30659195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.
    Dhawan P; Peng X; Sutton AL; MacDonald PN; Croniger CM; Trautwein C; Centrella M; McCarthy TL; Christakos S
    Mol Cell Biol; 2005 Jan; 25(1):472-87. PubMed ID: 15601867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
    Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
    Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells.
    Eaton EM; Hanlon M; Bundy L; Sealy L
    J Cell Physiol; 2001 Oct; 189(1):91-105. PubMed ID: 11573208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta.
    Seymour KJ; Roberts LE; Fini MA; Parmley LA; Oustitch TL; Wright RM
    J Biol Chem; 2006 Mar; 281(13):8545-58. PubMed ID: 16452486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCAAT/enhancer-binding protein beta isoforms and the regulation of alpha-smooth muscle actin gene expression by IL-1 beta.
    Hu B; Wu Z; Jin H; Hashimoto N; Liu T; Phan SH
    J Immunol; 2004 Oct; 173(7):4661-8. PubMed ID: 15383601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of new sites of binding and activation of the murine alpha1(I) collagen promoter by CCAAT/enhancer binding protein beta.
    Attard FA; Wang L; Potter JJ; Rennie-Tankersley L; Mezey E
    DNA Cell Biol; 2001 Aug; 20(8):455-63. PubMed ID: 11560777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis.
    Zhang JW; Klemm DJ; Vinson C; Lane MD
    J Biol Chem; 2004 Feb; 279(6):4471-8. PubMed ID: 14593102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.
    Gomis RR; Alarcón C; Nadal C; Van Poznak C; Massagué J
    Cancer Cell; 2006 Sep; 10(3):203-14. PubMed ID: 16959612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer.
    Ma J; DeFrances MC; Zou C; Johnson C; Ferrell R; Zarnegar R
    J Clin Invest; 2009 Mar; 119(3):478-91. PubMed ID: 19188684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.